home





























 


















 






















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS:
JUNE 2001





Update on Drug Resistance Mutations in HIV-1 [D'Aquila RT et al. Topics in HIV Medicine 2001; 9: 31]
posted 6/22/2001

End-of-Life Discussions and Preferences Among Persons With HIV [Wenger NS et al. JAMA 2001; 285: 2880]
posted 6/22/2001

HIV and AIDS - United States, 1981-2000 [CDC: MMWR 2001; 50: 430]
posted 6/22/2001

HIV Incidence Among Young Men Who Have Sex With Men - Seven U.S. Cities, 1994-2000 [CDC: MMWR 2001; 50: 440]
posted 6/22/2001

Bristol-Myers Squibb buys DuPont Pharmaceuticals Company
posted 6/22/2001

Effects of virologic rebound on CD4 cell counts [Bahrani A et al. CID 2001; 32: 1231]
posted 6/20/2001

Resistance study to re-evaluate HAART [Kenyon G. Nat Medicine 2001; 7: 515]
posted 6/20/2001

Fatal portal hypertension, liver failure and Mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidemia [Carr A et al. Lancet 2001; 357: 1412]
posted 6/20/2001

Disputed AIDS theory dies its final death [Cohen J Science 2001; 292: 615]
posted 6/20/2001

Chronic Hyperlactatemia in HIV-infected Patients taking antiretroviral therapy [John M et al. AIDS 2001; 15: 717]
posted 6/20/2001

Viral Load differences in early infection with two HIV-1 subtypes [Hu DJ et al. AIDS 2001; 15: 683]
posted 6/20/2001

HIV-infected pregnant women and vertical transmission in Europe since 1986 [European Collaborative Study. AIDS 2001;15:761]
posted 6/20/2001

A Randomized, Controlled Trial of Interventions to Improve Adherence to Isoniazid Therapy to Prevent Tuberculosis in Injection Drug Users [Chaisson RE et al. Am J Med 2001; 110: 610]
posted 6/14/2001

Herpes Zoster as an Immune Reconstitution Disease after Initiation of Combination Antiretroviral Therapy in Patients with Human Immunodeficiency Virus Type-1 Infection [Domingo P et al. Am J Med 2001; 110: 605]
posted 6/14/2001

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus [Stoddart CA et al. Nature Medicine 2001; 7: 712]
posted 6/14/2001

HIV-Associated Coronary Arteritis in a Patient with Fatal Myocardial Infarction [Barbaro G et al. NEJM 2001; 344: 1799]
posted 6/14/2001

When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study [Lepri AC et al. AIDS 2001; 15: 983]
posted 6/7/2001

Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir [Kirk O et al. AIDS 2001; 15: 999]
posted 6/7/2001

HIV Budget for FY 2002 (OMB, FY 2002 Budget, April 2001)
posted 6/7/2001

Resistance to Antiretroviral Therapy Among Patients in Uganda [Weidle PJ et al. JAIDS 2001; 26: 495]
posted 6/1/2001

FDA warning on safety of Itraconazole (Sporanox)
posted 6/1/2001

 




Copyright © 2001-2002. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.